FI885025A0 - Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning. - Google Patents

Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.

Info

Publication number
FI885025A0
FI885025A0 FI885025A FI885025A FI885025A0 FI 885025 A0 FI885025 A0 FI 885025A0 FI 885025 A FI885025 A FI 885025A FI 885025 A FI885025 A FI 885025A FI 885025 A0 FI885025 A0 FI 885025A0
Authority
FI
Finland
Prior art keywords
protein
koagulationshaemmande
framstaellning och
dess framstaellning
och anvaendning
Prior art date
Application number
FI885025A
Other languages
English (en)
Other versions
FI885025A (fi
Inventor
Ulrich Grundmann
Karl-Josef Abel
Egon Amann
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of FI885025A0 publication Critical patent/FI885025A0/fi
Publication of FI885025A publication Critical patent/FI885025A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI885025A 1987-11-03 1988-11-01 Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning. FI885025A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873737237 DE3737237A1 (de) 1987-11-03 1987-11-03 Anticoagulatorisches protein pp4-x, seine herstellung und verwendung

Publications (2)

Publication Number Publication Date
FI885025A0 true FI885025A0 (fi) 1988-11-01
FI885025A FI885025A (fi) 1989-05-04

Family

ID=6339663

Family Applications (1)

Application Number Title Priority Date Filing Date
FI885025A FI885025A (fi) 1987-11-03 1988-11-01 Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.

Country Status (11)

Country Link
US (1) US5202419A (fi)
EP (1) EP0315081B1 (fi)
JP (1) JPH01165387A (fi)
KR (1) KR890008316A (fi)
AT (1) ATE109509T1 (fi)
AU (1) AU613676B2 (fi)
DE (2) DE3737237A1 (fi)
DK (1) DK610488A (fi)
ES (1) ES2056872T3 (fi)
FI (1) FI885025A (fi)
PT (1) PT88913B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68923107T2 (de) * 1988-02-26 1996-01-18 Biogen Inc DNA-Sequenzen, rekombinante DNA-Moleküle und Verfahren zur Herstellung von Lipocortin III, IV, V, und VI.
DE3939169A1 (de) * 1989-11-27 1991-05-29 Behringwerke Ag Verfahren zur reinigung von lipocortinen
DE4012341A1 (de) * 1990-04-18 1991-10-24 Behringwerke Ag Monoklonale antikoerper gegen pp4, verfahren zu ihrer herstellung und ihre verwendung
US5968477A (en) * 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315000A1 (de) * 1983-04-26 1984-10-31 Behringwerke Ag, 3550 Marburg Gewebeprotein pp(pfeil abwaerts)4(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung
HUT40695A (en) * 1985-01-10 1987-01-28 Biogen Nv Dna sequences, recombinant dna molecules and processes for preparing humane lipocortine like polypeptides
CA1265446A (en) * 1985-09-30 1990-02-06 Masahiro Maki Anticoagulating substance, process for preparing same and anticoagulant comprising same as an effective component
AU1299788A (en) * 1987-02-06 1988-08-24 Board Of Regents Of The University Of Washington, The Human proteins having anticoagulant and anti-inflammatory activity
US4937324A (en) * 1987-02-06 1990-06-26 Zymogenetics, Inc. Chromatographic purification of human proteins having anticoagulant and anti-inflammatory activity

Also Published As

Publication number Publication date
EP0315081A2 (de) 1989-05-10
DE3850933D1 (de) 1994-09-08
KR890008316A (ko) 1989-07-10
ATE109509T1 (de) 1994-08-15
AU2459188A (en) 1989-05-04
US5202419A (en) 1993-04-13
FI885025A (fi) 1989-05-04
DE3737237A1 (de) 1989-05-18
AU613676B2 (en) 1991-08-08
ES2056872T3 (es) 1994-10-16
DK610488A (da) 1989-05-04
PT88913B (pt) 1993-01-29
EP0315081A3 (en) 1990-05-30
DK610488D0 (da) 1988-11-02
JPH01165387A (ja) 1989-06-29
PT88913A (pt) 1988-12-01
EP0315081B1 (de) 1994-08-03

Similar Documents

Publication Publication Date Title
DE68929551D1 (de) Menschliche DNase
DE3382837T2 (de) Herstellung von funktionellen, menschlichen Urokinaseproteinen
ATE294864T1 (de) Äusseres membranprotein von haemophilus
KR880009035A (ko) Apc 폴리펩티드의 전구 단백질, 이를 위한 dna 암호화, 및 이 dna와 단백질의 진단 용도
FI946004A0 (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
FI882746A0 (fi) Hybridprotein c och foerfarande foer dess framstaellning.
DE3650135T2 (de) Proteingewinnung.
DE3771611D1 (de) Butensaeure-n-phenylamide mit pharmazeutischen eigenschaften.
ATE54826T1 (de) Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung.
ES2053712T3 (es) Un antigeno proteico reactivo y fragmentos del mismo.
FI885025A0 (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
DE3686684D1 (de) Mittel zur absorptionsverbesserung von proteinen.
ATE103635T1 (de) Reg-gen und dadurch kodiertes protein.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: BEHRINGWERKE AKTIENGESELLSCHAFT